Jefferies Group LLC Axonics, Inc. Call Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 13, 2020	SELL	$35.33 - $51.04 $325,036 - $469,568	-9,200 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $2.58 Million - $4.49 Million	-112,700 Reduced 92.45%	9,200 $323,000
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $1.49 Million - $3.41 Million	90,500 Added 288.22%	121,900 $3.1 Million
Q4 2019 Feb 13, 2020	BUY	$19.57 - $28.96 $614,498 - $909,344	31,400 New	31,400 $870,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.